Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds

Details for Australian Patent Application No. 2004258747 (hide)

Owner Innate Pharma Universita Degli Studi Di Perugia

Inventors Velardi, Andrea; Romagne, Francois

Agent Davies Collison Cave

Pub. Number AU-B-2004258747

PCT Pub. Number WO2005/009465

Priority 60/489,489 24.07.03 US

Filing date 23 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 19 November 2009

International Classifications

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009465 Priority application(s): WO2005/009465

19 November 2009 Application Accepted

  Published as AU-B-2004258747

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004258750-Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C

2004258746-Dispersible pharmaceutical composition for treatment of mastitis and otic disorders